Basilea Pharmaceutica Ltd
(XSWX:BSLN)
CHF
45.2
0.3 (0.67%)
Market Cap: 547.87 Mil
Enterprise Value: 597.36 Mil
PE Ratio: 71.26
PB Ratio: 0
GF Score: 68/100 Basilea Pharmaceutica Ltd (XSWX:BSLN) Transcripts
- Half Year 2024 Basilea Pharmaceutica AG Allschwil Earnings Call TranscriptAug 13, 2024CHF41 (+8.32%)Earnings
- Full Year 2023 Basilea Pharmaceutica AG Allschwil Earnings Call TranscriptFeb 13, 2024CHF36.5 (+8.79%)Earnings
- Basilea Pharmaceutica AG Allschwil to Acquire the Rights to Fosmanogepix from Amplyx Pharmaceuticals Inc Call TranscriptNov 13, 2023
- Half Year 2023 Basilea Pharmaceutica AG Allschwil Earnings Call TranscriptAug 15, 2023CHF47.35 (+11.67%)Earnings
- Full Year 2022 Basilea Pharmaceutica AG Earnings Call TranscriptFeb 14, 2023CHF49.55 (+3.55%)Earnings
- Half Year 2022 Basilea Pharmaceutica AG Earnings Call TranscriptAug 16, 2022CHF40.25 (-7.47%)Earnings
- Basilea Pharmaceutica AG to Discuss the ERADICATE Topline Results Call TranscriptJun 28, 2022
- Basilea Pharmaceutica AG at UBS Global Healthcare Conference TranscriptMay 24, 2022
- Full Year 2021 Basilea Pharmaceutica AG Earnings Call TranscriptFeb 15, 2022CHF41.72 (+4.04%)Earnings
- Half Year 2021 Basilea Pharmaceutica AG Earnings Call TranscriptAug 17, 2021CHF45.16 (-1.61%)Earnings
- Full Year 2020 Basilea Pharmaceutica AG Earnings Call TranscriptFeb 16, 2021CHF58.8 (-3.61%)Earnings
- Half Year 2020 Basilea Pharmaceutica AG Earnings Call TranscriptAug 11, 2020CHF49 (+4.66%)Earnings
- Basilea Pharmaceutica AG at UBS Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Full Year 2019 Basilea Pharmaceutica AG Earnings Call TranscriptFeb 18, 2020CHF56.35 (-5.77%)Earnings
- Half Year 2019 Basilea Pharmaceutica AG Earnings Call TranscriptAug 20, 2019CHF39.16 (+5.90%)Earnings
- Basilea Pharmaceutica AG at UBS Global Healthcare Conference TranscriptMay 21, 2019
- 1